Sort
40,608 grants matching “prostate cancer”
Center for Nutrient-Gene Interaction in Cancer Prevention
$1,793,809Stephen Barnes · University Of Alabama At Birmingham · U54 · FY2007 · CA
Harvard Transdisciplinary Research in Energetics and Cancer Center
$1,793,576Frank B Hu · Harvard School Of Public Health · U54 · FY2013 · CA
SPORE in Prostate Cancer
$1,793,395William George Nelson · Johns Hopkins University · P50 · FY2015 · CA
Molecular-Based Therapy for Oral Cancer Prevention
$1,792,413Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
INTEGRATIVE ANALYSIS OF EXITRONS IN METASTATIC PROSTATE CANCER
$1,791,704Regents Of The University Of Minnesota · · FY2019 · Defense Health Agency
Improving Cancer Outcome--Adaptive Helical Tomotherapy
$1,790,419University Of Wisconsin Madison · P01 · FY2004 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,786,679Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2009 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,786,679Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Mechanisms of Inorganic Carcinogenesis
$1,786,280Michael Waalkes · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Determinants of Liver Metastasis
$1,784,475Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Michigan Prostate SPORE
$1,783,426Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2019 · CA
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer
$1,783,381Kenneth Offit · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
FAMU RCMI Pharmaceutical Research Center
$1,783,083Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2017 · MD
Signaling and Progression in Prostate Cancer
$1,782,332Bryce M Paschal · University Of Virginia · P01 · FY2014 · CA
Cancer Epidemiology Cohort in Male Health Professionals
$1,782,165Walter C. Willett · Harvard School Of Public Health · U01 · FY2021 · CA
IDENTIFYING NOVEL DRUG TARGETS FOR LETHAL PROSTATE CANCER USING LIQUID BIOPSY
$1,782,155Mayo Clinic · · FY2025 · Defense Health Agency
Loma Linda University Center for Health Disparities Res*
$1,781,553Marino De Leon · Loma Linda University · P20 · FY2006 · MD
Signaling and Progression in Prostate Cancer
$1,781,224Dan Theodorescu · University Of Virginia · P01 · FY2008 · CA
TEMPORAL EVOLUTION OF N-MYC SIGNALING AND EARLY TARGETING OF THE NEUROENDOCRINE PHENOTYPE IN PROSTATE CANCER
$1,780,847Weill Medical College Of Cornell University · · FY2017 · Defense Health Agency
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
$1,780,770Besim Ogretmen · Medical University Of South Carolina · P01 · FY2017 · CA
Developmental Core
$1,778,233Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2010 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,777,919Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Comparative Mechanisms of Cancer Chemoprevention
$1,777,297Roderick H Dashwood · Oregon State University · P01 · FY2011 · CA
Enviromental Exposures, Host Factors and Human Disease
$1,777,053Frank D. Gilliland · University Of Southern California · P30 · FY2012 · ES
Enviromental Exposures, Host Factors and Human Disease
$1,777,053Frank D. Gilliland · University Of Southern California · P30 · FY2015 · ES